Labshake search
Citations for Tocris :
351 - 400 of 580 citations for 6 Amino 5 formamido uracil since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2024Quote: ... a 5% DMSO (Tocris Bioscience, Cat#: 3176; Batch: 68A) containing PBS (Corning ...
-
bioRxiv - Neuroscience 2019Quote: ... and NMDAR EPSCs were then isolated by addition of the AMPAR antagonist 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX, 10 µM; Tocris, Cat# 1044). NMDAR EPSCs were confirmed by addition of the NMDAR antagonist D,L-APV (20 µM ...
-
bioRxiv - Immunology 2021Quote: ... cells were stimulated with HDM or the known AhR agonist FICZ (5,11-Dihydroindolo[3,2-b]carbazole-6-carboxaldehyde, Tocris Bioscience ...
-
bioRxiv - Molecular Biology 2021Quote: ... culture medium was replaced by E6 medium supplemented with 6 μM CHIR (Tocris, Bio-Techne, Abingdon, United Kingdom) to initiate differentiation (defined as day 0) ...
-
bioRxiv - Neuroscience 2020Quote: ... to allow outside-out patch recording and 30 μM 2,3-dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX; Tocris, Cat#1044) was added to media post-transfection to avoid AMPAR-mediated toxicity.
-
bioRxiv - Neuroscience 2022Quote: ... 3,5-dichloro-N-[[(1α,5α,6-exo,6α)-3-(3,3-dimethylbutyl)-3-azabicyclo[3.1.0]hex-6-yl]methyl]-benzamide-hydrochloride (ML218 or ml) was purchased from TOCRIS and initially dissolved at 50 mM in DMSO ...
-
Pathogenic CD8 T cell responses are driven by neutrophil-mediated hypoxia in cutaneous leishmaniasisbioRxiv - Immunology 2023Quote: ... the sections were counter-stained with the nuclear probe 4’,6-diamino-2-phenylindole (DAPI, Biotechne-Tocris, UK). Slides were covered with Prolong™ Gold Antifade Mountant (Invitrogen ...
-
bioRxiv - Physiology 2023Quote: ... animals either received vehicle (1 µl DMSO; n = 6) or the DREADD ligand clozapine n-oxide (CNO, Tocris; 0.1 mg/µl DMSO ...
-
bioRxiv - Developmental Biology 2020Quote: ... and 10 μM ALK4/5/7 kinase inhibitor SB431542 (Tocris) at 37 °C in 5% CO2 ...
-
bioRxiv - Biophysics 2022Quote: ... SEC purified protein was mixed with 5 mM ATPγS (TOCRIS) and 5 mM MgCl2 for 20 minutes at room temperature and concentrated to 0.5 - 1.0 mg ml-1 ...
-
bioRxiv - Neuroscience 2021Quote: ... and agonist WAY 267464 dihydrochloride (Tocris Biosciences, 3933, 5 μM) were added to each dish from the beginning of the isolation period (2hrs prior to adding fluorescently-labeled paramecia).
-
bioRxiv - Bioengineering 2022Quote: ... Y-27632 (10 μM; Seleckchem) and CHIR99021 (5 μM;. Tocris). Jejunal organoids were split every 7 to 9 days as previously described.[112] Based on this established protocol ...
-
bioRxiv - Genomics 2019Quote: ... ER stress was induced by adding 5 µM Tunicamycin (Tocris) for 24 hours.
-
bioRxiv - Neuroscience 2021Quote: ... as well as 5 µg/mL insulin (Tocris Bioscience Inc), 1 mM GlutaMAX ...
-
bioRxiv - Cell Biology 2022Quote: ... TGF-β inhibitor A 83-01 (5 uM, Tocris bioscience), VEGF-121 (10 ng/mL ...
-
bioRxiv - Neuroscience 2021Quote: ... α,β-methyleneadenosine 5’-triphosphate trisodium salt (TOCRIS: Cat. 3209), hydrochloride were dissolved into 100 mM stock in Milli-Q water and further diluted into different concentrations ...
-
bioRxiv - Cancer Biology 2022Quote: ... alone or with 5 μM AR-C118925XX (AR-C, Tocris) or 10 μM cycloRGDfV (cRGDfV ...
-
bioRxiv - Neuroscience 2022Quote: ... XAV939 (5 μM; catalog#3748, Tocris Bioscience, Bristol, United Kingdom), PD0325901 (1 μM ...
-
bioRxiv - Neuroscience 2019Quote: ... the selective D3 receptor antagonist SB 27701A (5 µM; Tocris); the selective D4 receptor antagonist L-745 ...
-
bioRxiv - Neuroscience 2020Quote: ... saturated with 95 % O2/5 % CO2 (drugs from Tocris Bioscience). 3–6 MΩ borosilicate pipettes were filled with intracellular solution (containing in mM ...
-
bioRxiv - Cell Biology 2022Quote: ... resuspended in 5% FBS + 0.5% BSA + 10mm Y-27632 (Tocris) in PBS and sorted for viability by exclusion of Sytox Blue dead cell stain (Thermo Fisher Scientific ...
-
bioRxiv - Neuroscience 2023Quote: ... 4-AP (100 µM, Tocris, 0940, CAS: 504-24-5), CNQX (20 µM ...
-
bioRxiv - Cancer Biology 2022Quote: ... or adenosine 5’-[γ-thio]triphosphate tetralithium salt (ATPγS, Tocris) alone or with 5 μM AR-C118925XX (AR-C ...
-
bioRxiv - Cancer Biology 2023Quote: ... TGF-β inhibitor A 83-01 (5 uM, Tocris bioscience), Fungin (10μg/ml ...
-
bioRxiv - Neuroscience 2023Quote: ... Step 2: synaptic blockers (50µm DL-AP-5 (Tocris #0105), 40µm L-AP4 (Tocris #0103) ...
-
bioRxiv - Bioengineering 2024Quote: ... 5 μM Y-27632 dihydrochloride (Tocris Bioscience, cat. no. 1254), a rho-associated protein kinase (ROCK ...
-
bioRxiv - Neuroscience 2023Quote: ... 20 L-AP4 (Alomone Labs) and 2-5 ACET (Tocris) (Park et al. ...
-
bioRxiv - Neuroscience 2021Quote: ... The resulting cell pellet was broken up and resuspended in 1ml E8 media by 1000ul pipette and distributed on a Geltrex coated 6 well plate with E8 and 10µM ROCK inhibitor (Y-27632 dihydrochloride, Tocris) for 24 hours ...
-
bioRxiv - Neuroscience 2020Quote: ... and re-plated at 1:6 ratio on Matrigel-coated plate in neural medium supplemented with 1μM CHIR99021 (Tocris), 2μM DMH1 (Tocris) ...
-
bioRxiv - Neuroscience 2020Quote: ... and re-plated at 1:6 ratio on Matrigel-coated plate in neural medium supplemented with 3μM CHIR99021 (Tocris), 2μM DMH1 (Tocris) ...
-
bioRxiv - Cell Biology 2021Quote: ... or the AMPA-iGluR specific inhibitor 2,3-dioxo-6-nitro-7-sulfamoyl-benzo[f]quinoxaline (NBQX, cat. num. 373, Tocris). Drugs were dissolved in ESC complete media (no 2i ...
-
bioRxiv - Neuroscience 2022Quote: ... were recorded during the application of the competitive AMPA/kainate receptor antagonist 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX; 20 μM, Tocris) and the selective NMDA receptor antagonist amino-5-phosphonopentanoic acid (AP5 ...
-
bioRxiv - Neuroscience 2019Quote: ... in the presence of the mGluR5 antagonist 2-methyl-6 (phenylethynyl)-pyridine (MPEP, 25 μM; Tocris Bioscience, Bristol, UK). Inhibitors were applied concomitantly from 30 min before to 30 min after DHPG/MPEP treatment ...
-
bioRxiv - Neuroscience 2019Quote: ... 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (“NBQX”, 100 mM in DMSO, Tocris Cat No 0373); D-2-amino-5-phosphonovalerate (“D-AP5” ...
-
bioRxiv - Neuroscience 2021Quote: ... The mGluR5 specific negative allosteric modulator MPEP hydrochloride (2-Methyl-6-(phenylethynyl)pyridine hydrochloride) was purchased from Tocris (1212) and administered to brain slices at 30 μM by bath perfusion ...
-
bioRxiv - Molecular Biology 2022Quote: ... 6 replicates of each condition were treated with DMSO or 100 nM dTAG13 (Tocris Bioscience, Fisher Scientific 66-055) for 2 hours ...
-
bioRxiv - Neuroscience 2022Quote: ... drugs were bath applied at the following concentrations (in μM): 10 6-Cyano-7-nitroquinoxaline-2,3-dione disodium salt (CNQX, Tocris), 50 D-2-amino-5-phosphonopentanoic acid (D-APV ...
-
bioRxiv - Cell Biology 2022Quote: ... Neuroectoderm was induced for 6 days in CDM-BSA supplemented with 12ng/ml FGF2 and 10μM SB431542 (Activin/Nodal/TGFβ inhibitor; Tocris), as previously described34 ...
-
bioRxiv - Immunology 2023Quote: Co-culture assays: thymocytes were isolated from untreated C57BL/6 mice and incubated with Nigericin (10 µM, Tocris, 4312) and LPS (1 ng/ml ...
-
Sexual differences in neuronal and synaptic properties across subregions of the mouse insular cortexbioRxiv - Neuroscience 2023Quote: ... were recorded at −70mV in presence of 20□μM CNQX (6-Cyano-7-nitroquinoxaline-2,3-dione disodium, an AMPA receptor antagonist, Tocris) and L-APV 50 μM (DL-2-Amino-5-phosphonopentanoic acid ...
-
bioRxiv - Cell Biology 2024Quote: ... Cultures were passaged every 6 days and kept in a cycle of 3 days in 5μM ROCK inhibitor (Y-27632 dihydrochloride; Tocris), 3 days in the absence of rock inhibitor ...
-
bioRxiv - Neuroscience 2021Quote: ... the OXT antagonist L-368,899 hydrochloride (Tocris Biosciences, 2641, 5 μM) and agonist WAY 267464 dihydrochloride (Tocris Biosciences ...
-
bioRxiv - Bioengineering 2021Quote: ... and TGF-βinhibitor (SB431542, Tocris, 1614, 5 µM, days 0-10). On Day 2 ...
-
bioRxiv - Neuroscience 2021Quote: ... 4- aminopyridine (Tocris Bioscience, 50 µM, 5 min-2hrs or 20hrs), AP5 (Tocris Bioscience ...
-
bioRxiv - Neuroscience 2022Quote: ... where N2 medium was supplemented with SB431542 (5 µM, Tocris, 1614), XAV939 (1 µM ...
-
bioRxiv - Cell Biology 2021Quote: ... 10 μl dilution buffer containing 5 μM A-485 (Tocris, 6387) were added and reaction allowed to equilibrate at room temperature for 10 min ...
-
bioRxiv - Neuroscience 2022Quote: ... cells were incubated for 1 h with 5 µM GsMTx4 (Tocris) or 15 and 30 min with 1 µM soluble Aβ1-42 (Bachem ...
-
bioRxiv - Neuroscience 2022Quote: ... where N2 medium was supplemented with SB431542 (5 μM, Tocris, 1614), XAV939 (1 μM ...
-
bioRxiv - Cell Biology 2023Quote: ... For drug treatments: AACOCF3 (selective phospholipase A2 inhibitor, Tocris #1462-5), CK666 (selective Arp2/3 inhibitor ...
-
bioRxiv - Neuroscience 2023Quote: ... and Clozapine N-oxide dihydrochloride (CNO, 5 mg/kg, Tocris Bioscence) were dissolved in sterile 0.9% NaCl (saline) ...